Respironics Inc, Murrysville, Pa, has sold its Novametrix pulse oximetry product line to Dixtal Medical.
Dixtal’s parent company, Brazil-based Dixtal Biomedica, has conducted business with Novametrix for many years, with Dixtal Biomedica manufacturing and marketing Novametrix pulse oximetry products for the Brazilian hospital market.
After Respironics’ 2002 acquisition of Novametrix, the company later determined that the Novametrix pulse ox line was not a core technology for Respironics and “made the decision to exit this line of business and refocus on its core technologies.”
Respironics made known its intention to sell Novametrix during its July 2007 quarterly earnings conference call, including the impact of the divestiture in its guidance. The Novametrix sale is not considered a material transaction for Respironics.
To view the full news release, click here.
